| Item 1. | |
| (a) | Name of issuer:
PRECISION BIOSCIENCES INC |
| (b) | Address of issuer's principal executive offices:
302 EAST PETTIGREW STREET SUITE A-100, DURHAM, NC, 27701 |
| Item 2. | |
| (a) | Name of person filing:
This statement is filed on behalf of the following persons with respect to the shares of Common Stock of the Issuer:
(i) Novartis Pharma AG, a Swiss corporation ("Novartis Pharma"), with respect to shares held by it; and
(ii) Novartis AG, a Swiss corporation ("Novartis"), as the publicly-owned parent of Novartis Pharma, with respect to the shares held by Novartis Pharma.
The foregoing persons are hereinafter referred to collectively as the "Reporting Persons." |
| (b) | Address or principal business office or, if none, residence:
The address of the principal business offices of the Reporting Persons is Lichtstrasse 35, CH-4056 Basel, Switzerland. |
| (c) | Citizenship:
Novartis Pharma is a corporation organized under the laws of Switzerland and is a direct wholly-owned subsidiary of Novartis.
Novartis is a corporation organized under the laws of Switzerland and is the publicly-owned parent of Novartis Pharma. |
| (d) | Title of class of securities:
Common stock, par value $0.000005 per share |
| (e) | CUSIP No.:
74019P207 |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) |  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
|
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
|
| | |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
The information required by Items 4(a)-(c) with respect to each Reporting Person is set forth in Rows 5
through 9 and 11 of the cover page to this Schedule 13G. The ownership percentages reported are
based on 11,088,234 outstanding shares of Common Stock, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 15, 2025. |
| (b) | Percent of class:
|
| (c) | Number of shares as to which the person has:
|
| | (i) Sole power to vote or to direct the vote:
|
| | (ii) Shared power to vote or to direct the vote:
|
| | (iii) Sole power to dispose or to direct the disposition of:
|
| | (iv) Shared power to dispose or to direct the disposition of:
|
| Item 5. | Ownership of 5 Percent or Less of a Class. |
| | 
Ownership of 5 percent or less of a class
|
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
| |
Not Applicable
|
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
Not Applicable
|
| Item 8. | Identification and Classification of Members of the Group. |
| |
Not Applicable
|
| Item 9. | Notice of Dissolution of Group. |
| |
Not Applicable
|